THE COMPARATIVE EFFICACY OF TELAPREVIR VERSUS BOCEPREVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS

被引：2
|
作者：
Diels, J. [1 ]
Cure, S. [2 ]
Gavart, S. [3 ]
机构：
[1] Janssen Pharmaceut NV, Janssen EMEA Hlth Econ & Market Access, Beerse, Belgium
[2] I3 Innovus, Uxbridge, Middx, England
[3] Janssen Pharmaceut NV, Worldwide Market Access, Janssen Global Serv, Beerse, Belgium
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.195
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A266 / A266
页数：1
相关论文
共 50 条
  • [21] Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: The effect of pegylated interferon plus ribavirin treatment
    Elefsiniotis, Ioannis S.
    Vezali, Elena
    Kamposioras, Konstantinos
    D Pantazis, Konstantinos
    Tontorova, Raclostina
    Ketikoglou, Ioannis
    Moulakakis, Antonios
    Saroglou, George
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (27) : 4420 - 4424
  • [22] SOFOSBUVIR PLUS RIBAVIRIN, AN INTERFERON-FREE REGIMEN, IN THE TREATMENT OF TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH CHRONIC GENOTYPE 4 HCV INFECTION
    Ruane, P. J.
    Ain, D.
    Meshrekey, R.
    Riad, J.
    Soliman, M.
    Mikhail, S.
    Wolfe, P. R.
    Kersey, K.
    Doehle, B.
    Jiang, D.
    Symonds, W. T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S503 - S504
  • [23] C-SURFER: GRAZOPREVIR PLUS ELBASVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE 1 INFECTION AND CHRONIC KIDNEY DISEASE (CKD)
    Bruchfeld, A.
    Roth, D.
    Nelson, D.
    Liapakis, A.
    Silva, M.
    Monsour, H., Jr.
    Martin, P.
    Pol, S.
    Londono, M. -C.
    Hassanein, T.
    Zamor, P.
    Zuckerman, E.
    Zhao, Y.
    Robertson, M.
    Wahl, J.
    Barr, E.
    Greaves, W.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 10 - 10
  • [24] Treatment of experienced and naive patients with hepatitis C: focus on telaprevir
    D'Ambrosio, Roberta
    Aghemo, Alessio
    Colombo, Massimo
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 363 - 370
  • [25] Pharmacokinetics of Sifuvirtide in Treatment-Naive and Treatment-Experienced HIV-Infected Patients
    Meng, Qingfang
    Dong, Tianhao
    Chen, Xin
    Tong, Baohui
    Qian, Xiaohong
    Che, Jinjing
    Cheng, Yuanguo
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (12) : 4038 - 4047
  • [26] Response to tenofovir treatment of treatment-naive and adefovir experienced patients with chronic hepatitis b
    Keskin, Onur
    Ormeci, Asli Cifcibasi
    Kabacam, Gokhan
    Akyuz, Filiz
    Aniktar, Hatice
    Karaca, Cetin
    Idilman, Ramazan
    Kaymakoglu, Sabahattin
    Yurdaydin, Cihan
    HEPATOLOGY, 2012, 56 : 394A - 395A
  • [27] Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B
    Keskin, Onur
    Ormeci, Asli C.
    Baran, Bulent
    Kabacam, Gokhan
    Tuzun, Ali
    Karatayli, Ersin
    Akyuz, Filiz
    Karatayli, Senem
    Bozdayi, A. Mithat
    Onel, Derya
    Badur, Selim
    Idilman, Ramazan
    Kaymakoglu, Sabahattin
    Yurdaydin, Cihan
    ANTIVIRAL THERAPY, 2014, 19 (06) : 543 - 550
  • [28] Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3
    Silva, Marcelo O.
    Treitel, Michelle
    Graham, Donald J.
    Curry, Stephanie
    Frontera, Maria J.
    McMonagle, Patricia
    Gupta, Samir
    Hughes, Eric
    Chase, Robert
    Lahser, Fred
    Barnard, Richard J. O.
    Howe, Anita Y. M.
    Howe, John A.
    JOURNAL OF HEPATOLOGY, 2013, 59 (01) : 31 - 37
  • [29] Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naive and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis
    El Raziky, M.
    Gamil, M.
    Ashour, M. K.
    Sameea, E. A.
    Doss, W.
    Hamada, Y.
    Van Dooren, G.
    DeMasi, R.
    Keim, S.
    Lonjon-Domanec, I.
    Hammad, R.
    Hashim, M. S.
    Hassany, M.
    Waked, I.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (02) : 102 - 110
  • [30] A Real Life Boceprevir Use in Treatment-Experienced HCV Genotype 1 Patients with Advanced Fibrosis
    Gheorghe, Liana
    Iacob, Speranta
    Simionov, Iulia
    Caruntu, Florin
    Motoc, Adriana
    Arama, Victoria
    Preotescu, Liliana
    Stefan, Ion
    Goldis, Adrian
    Brisc, Cristian
    Rugina, Sorin
    Rednic, Nicolae
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2014, 23 (01) : 45 - 50
12345